Blood-cell producing bio-microreactor
US-2016097033-A1 · Apr 7, 2016 · US
US12180447B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12180447-B2 |
| Application number | US-202318343514-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 28, 2023 |
| Priority date | Mar 24, 2017 |
| Publication date | Dec 31, 2024 |
| Grant date | Dec 31, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to a microfluidic devices and methods for culturing bone marrow cells. Aspects include methods of preparing microfluidic devices and culturing bone marrow cells with the microfluidic devices. In some aspects, a method includes providing a microfluidic device having an upper chamber, a lower chamber, and a porous membrane separating the upper chamber from the lower chamber. The method further includes seeding walls of the lower chamber and a bottom surface of the membrane with endothelial cells. The method further includes providing a matrix within the upper chamber. The matrix includes fibrin gel and bone marrow cells. The method further includes filling or perfusing the upper chamber with a media.
Opening claim text (preview).
What is claimed is: 1. A method of preparing a microfluidic device, the method comprising: providing a microfluidic device having a first microchannel, a second microchannel, and a porous membrane separating the first microchannel from the second microchannel; providing a matrix within the first microchannel, the matrix comprising CD34+ bone marrow progenitor cells; perfusing media through the second microchannel; producing cells differentiated from said CD34+ bone marrow progenitor cells, said differentiated cells comprising erythroid lineage cells. 2. The method of claim 1 , wherein the matrix is a fibrin gel. 3. The method of claim 2 , wherein said fibrin gel comprises aprotinin. 4. The method of claim 1 , further comprising seeding the second microchannel with endothelial cells. 5. The method of claim 1 , wherein the first microchannel forms a closed channel. 6. The method of claim 1 , wherein said matrix further comprises stromal cells. 7. The method of claim 1 , wherein there is no flow of media through said first microchannel. 8. The method of claim 7 , wherein media in said second microchannel can migrate through said membrane into said first microchannel.
for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics · CPC title
Substrates of biological origin, e.g. extracellular matrix, decellularised tissue · CPC title
Fibrin; Thrombin · CPC title
Collagen; Gelatin · CPC title
Vascular endothelial cells · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.